Coronavirus Information for Ryan White HIV/AIDS Program Recipients and Partners

Content From: Laura Cheever, MD, ScM, Associate Administrator for the HIV/AIDS Bureau, Health Resources and Services Administration, U.S. Department of Health and Human Services, and Heather Hauck, MSW, LICSW, Deputy Associate Administrator for the HIV/AIDS Bureau, Health Resources and Services Administration, U.S. Department of Health and Human Services•Published: March 19, 2020•1 min read

Topics

HAB COVID-19

We know that many of HRSA’s Ryan White HIV/AIDS Program recipients, subrecipients, and stakeholders are concerned about novel coronavirus (COVID-19). HRSA’s Ryan White HIV/AIDS Program recipients provide a comprehensive system of HIV primary medical care, medication, and essential support services to the most vulnerable people with HIV, and many are playing an important role in delivering critical services and assisting local communities during this public health emergency.

HRSA is working to keep Ryan White HIV/AIDS Program recipients, subrecipients, and partners updated on the latest information regarding COVID-19. As part of that effort, HRSA’s HIV/AIDS Bureau (HAB) has launched a Frequently Asked Question (FAQ) webpage on the HAB website, which HAB is monitoring and updating as new information is made available.

Up-to-date information about COVID-19 is available from the Centers for Disease Control and Prevention. As always, please reach out to your HRSA HAB Project Officer with any additional questions.

Related HIV.gov Blogs

Nov 13, 2024

A Transition in HRSA’s HIV/AIDS Bureau

Oct 25, 2024

CDC Recommends Second Dose of 2024-2025 COVID-19 Vaccine for People 65 Years and Older and for People Who Are Moderately or Severely Immunocompromised

Sep 27, 2024

EHE Successes, Social Determinants of Health, and More: Final Conversation from the 2024 National Ryan White Conference

Topics